Diagnosis and treatment of dyspeptic patients in Japan

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue SUPPL. 3, 2011, Pages 27-31

  Manabe, Noriaki ^a   Haruma, Ken ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Diagnosis; Functional dyspepsia; Medical treatment; Rome III classification

Indexed keywords

HERBACEOUS AGENT; HISTAMINE H2 RECEPTOR AGONIST; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DYSPEPSIA; ERADICATION THERAPY; FUNCTIONAL DYSPEPSIA; HELICOBACTER PYLORI; HERBAL MEDICINE; HUMAN; JAPAN; MEDICAL ASSESSMENT; NONHUMAN; PATHOGENESIS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW;

EID: 79953106859     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06628.x     Document Type: Review

References (33)

1. Veldhuyzen van Zanten SJ, Flook N, Chiba N etal. An evidence-based approach to the management of patients with dyspepsia in the era of Helicobacter pylori. CMAJ 2000; 162: S3-23.
2. Nakajima S, Takahashi K, Sato J etal. Spectra of functional gastrointestinal disorders diagnosed by Rome III integrative questionnaire in a Japanese outpatient office and the impact of overlapping. J. Gastroenterol. Hepatol. 2010; 25 (Suppl. 1): S138-43.
3. Talley NJ, Silverstein MD, Agréus L, Nyrén O, Sonnenberg A, Holtmann G. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 1998; 114: 582-95.
4. Talley NJ, Weaver AL, Zinsmeister AR. Impact of functional dyspepsia on quality of life. Dig. Dis. Sci. 1995; 40: 584-9.
5. Goh KL. Changing trends in gastrointestinal disease in the Asia-Pacific region. J. Dig. Dis. 2007; 8: 179-85.
6. El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998; 43: 327-33.
7. Wong SN, Sollano JD, Chan MM etal. Changing trends in peptic ulcer prevalence in a tertiary care setting in the Phillippines: a seven-year study. J. Gastroenterol. Hepatol. 2005; 20: 628-32.
8. Fujimoto K. Prevalence and epidemiology of gastro-oesophageal reflux disease in Japan. Aliment. Pharmacol. Ther. 2004; 20 (Suppl. 8): 5-8.
9. Manabe N, Haruma K, Hata J, Kusunoki H, Kamada T. Changes in upper gastrointestinal symptoms and endoscopic findings in Japan during the past 15years. Gastroenterology 2007; 132: A344.
10. Yamaoka M, Nakajima S. Prevalence of subjects at a high or very high risk of gastric cancer in Japan. Gut Liver 2009; 3: 95-100.
11. Take S, Mizuno M, Ishiki K etal. The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori. J. Gastroenterol. 2010. DOI: 10.1007/s00535-010-0347-9. [Epub ahead of print].
12. Tack J. Functional Dyspepsia: impaired Fundic Accommodation. Curr. Treat. Options Gastroenterol. 2000; 3: 287-94.
13. Manabe N, Nakamura K, Hara M etal. Impaired gastric response to modified sham feeding in patients with postprandial distress syndrome. Neurogastroenterol. Motil. 2010. DOI: 10.1111/j.1365-2982.2010.01622.x. [Epub ahead of print].
14. Mizuta Y, Shikuwa S, Isomoto H etal. Recent insights into digestive motility in functional dyspepsia. J. Gastroenterol. 2006; 41: 1025-40.
15. Talley NJ. Scope of the problem of functional digestive disorders. Eur. J. Surg. 1998; 582: 35-41.
16. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: population-based study in Olmsted Country, Minnesota. Gastroenterology 1997; 112: 1448-56.
17. Geeraerts B, Tack J. Functional dyspepsia: past, present, and future. J. Gastroenterol. 2008; 43: 251-5.
18. Drossman DA. The gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130: 1377-90.
19. Manabe N, Haruma K, Hata J etal. Clinical characteristics of Japanese dyspeptic patients: is the Rome III classification applicable? Scand. J. Gastroenterol. 2010; 45: 567-72.
20. Tack J. Pathophysiology and treatment of functional dyspepsia. J. Clin. Gastroenterol. 2005; 39 (Suppl. 3): S211-6.
21. Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2004; 127: 1239-55.
22. Suzuki H, Nishizawa T, Hibi T. Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification. J. Gastroenterol. 2006; 41: 513-23.
23. Talley NJ, Meineche-Schmidt V, Paré P etal. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment. Pharmacol. Ther. 1998; 12: 1055-65.
24. Soo S, Moayyedi P, Deeks J etal. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst. Rev. 2000; 2: CD001960.
25. Veldhuyzen van Zanten SJ, Chiba N, Armstrong D etal. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study. Am. J. Gastroenterol. 2005; 100: 1477-88.
26. Talley NJ. Review article: functional dyspepsia-should treatment be targeted on disturbed physiology? Aliment. Pharamcol. Ther. 1995; 9: 107-15.
27. Hsu YC, Liou JM, Yang TH etal. Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups? J. Gastroenterol. 2010. DOI: 10.1007/s00535-010-0334-1. [Epub ahead of print].
28. Stanghellini V, Tosetti C, Paternicò A etal. Predominant symptoms identify different subgroups in functional dyspepsia. Am. J. Gastroenterol. 1999; 94: 2080-5.
29. Talley NJ, Shuter B, McCrudden G, Jones M, Hoschl R, Piper DW. Lack of association between gastric emptying of solids and symptoms in nonulcer dyspepsia. J. Clin. Gastroenterol. 1989; 11: 625-30.
30. Sarnelli G, Caenepeel P, Geypens B, Janssens J, Tack J. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am. J. Gastroenterol. 2003; 98: 783-8.
31. Laheij RJ, De Koning RW, Horrevorts AM etal. Predominant symptom behavior in patients with persistent dyspepsia during treatment. J. Clin. Gastroenterol. 2004; 38: 490-5.
32. Kawamura A, Adachi K, Takashima T etal. Prevalence of functional dyspepsia and its relationship with Helicobacter pylori infection in a Japanese population. J. Gastroenterol. Hepatol. 2001; 16: 384-8.
33. Hongo M, Kanatsuka H, Sugawara A etal. Primary care in the treatment of functional gastrointestinal symptoms in Japan: prescription preferences and impression of results. Aliment. Pharmacol. Ther. 2005; 21 (Suppl. 2): 47-54.